T3D Therapeutics' Unattributed - II Round

T3D Therapeutics raised a round of funding on March 13, 2015.

T3D Therapeutics is a privately-held pharmaceutical R&D company developing and commercializing T3D-959, potentially an optimal disease remedial therapeutic for the treatment of Alzheimer's Disease. Un…

Articles about T3D Therapeutics' Unattributed - II Round: